Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Passage Bio Inc (NQ: PASG ) 0.6294 +0.0144 (+2.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Passage Bio Inc < Previous 1 2 Next > Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference October 24, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference September 23, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024) September 16, 2024 From Passage Bio Via GlobeNewswire Passage Bio Welcomes Tom Kassberg to Board of Directors September 10, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference August 30, 2024 From Passage Bio Via GlobeNewswire Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights August 08, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences August 06, 2024 From Passage Bio Via GlobeNewswire Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration August 01, 2024 From Passage Bio Via GlobeNewswire Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients July 16, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Passage Bio Via GlobeNewswire Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights May 14, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit April 22, 2024 From Passage Bio Via GlobeNewswire Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights March 04, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences February 27, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference January 31, 2024 From Passage Bio Via GlobeNewswire Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities December 20, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) November 17, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights November 13, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference October 30, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 20, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference September 25, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights August 07, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Promising Interim Clinical Data from First Eight Patients with GM1 Gangliosidosis in Imagine-1 Study August 07, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences August 01, 2023 From Passage Bio Via GlobeNewswire Passage Bio Welcomes Dolan Sondhi, Ph.D. to Board Of Directors July 31, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Goldman Sachs 44th Annual Global Healthcare Conference June 05, 2023 From Passage Bio Via GlobeNewswire Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights May 11, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) April 21, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit April 17, 2023 From Passage Bio Via GlobeNewswire Passage Bio to Present at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days March 27, 2023 From Passage Bio Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
